Inflammation and neural signaling: Etiologic mechanisms of the cancer treatment-related symptom cluster

Current Opinion in Supportive and Palliative Care

Volumn 7, Issue 1, 2013, Pages 54-59

  Wood, Lisa J ^a   Weymann, Kristianna ^b  

^a MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cancer; Fatigue; Inflammation; Interleukin 1 ; Sickness behavior

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

BLOOD; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG EFFECT; FATIGUE; HUMAN; HYPOTHALAMUS; ILLNESS BEHAVIOR; INFLAMMATION; MOOD DISORDER; NEOPLASM; PHYSIOLOGY; QUALITY OF LIFE; REVIEW; SICKNESS IMPACT PROFILE; SIGNAL TRANSDUCTION; SYNDROME;

ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; FATIGUE; HUMANS; HYPOTHALAMUS; ILLNESS BEHAVIOR; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MOOD DISORDERS; NEOPLASMS; QUALITY OF LIFE; RECEPTORS, INTERLEUKIN; RECEPTORS, TUMOR NECROSIS FACTOR; SICKNESS IMPACT PROFILE; SIGNAL TRANSDUCTION; SYNDROME;

EID: 84877939784     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32835dabe3     Document Type: Review

References (36)

1. Wang XS, Williams LA, Krishnan S, et al. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun 2012;26:699-705.
2. Oh HS, Seo WS. Systematic review and meta-analysis of the correlates of cancer-related fatigue. Worldviews Evid Based Nurs 2011;8:191-201.
3. Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer 2012;118 (8 Suppl):2261-2269.
4. Sauter KA, Wood LJ, Wong J, et al. Doxorubicin and daunorubicin induce processing and release of interleukin-1beta through activation of the NLRP3 inflammasome. Cancer Biol Ther 2011;11:1008-1016. This article demonstrates for the first time that a CCA initiates the formation of the NLRP3 inflammasome to promote the secretion of IL-1b by immune cells. This finding supports the idea that symptoms related to exposure to cytotoxic agents may be caused by IL-1b.
5. Wong J, Smith LB, Magun EA, et al. Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin. Cancer Biol Ther 2012;14:56-63. This article demonstrates the central role that ZAK plays in doxorubicin-induced IL-1b production by immune cells. Nilotinib and sorafenib, which target ZAK, block doxorubicin-induced IL-1b production and consequently may be useful in reducing CTRSs.
6. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev 2008;8:279-289.
7. Tsuji E, Hiki N, Nomura S, et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003;107:303-308.
8. Cerci C, Ergin C, Eroglu E, et al. Effects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats. World J Gastroenterol 2007;13:2596-2599.
9. Karaman MW, Herrgard S, Treiber DK, et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008;26:127-132.
10. Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009;15:1170-1178.
11. Bamias G, Corridoni D, Pizarro TT, Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012;59:451-459.
12. Adelman JS, Martin LB. Vertebrate sickness behaviors: adaptive and integrated neuroendocrine immune responses. Integr Comp Biol 2009;49:202-214.
13. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457.
14. Braun TP, Zhu X, Szumowski M, et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med 2011;208:2449-2463.
15. Morceau F, Dicato M, Diederich M. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediat Inflamm 2009;2009:405016.
16. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011;130:226-238.
17. Grossberg AJ, Zhu X, Leinninger GM, et al. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci 2011;31: 11376-11386. This article demonstrates that suppressed orexin neuron activity is associated with the measured fatigue/lethargy outcome and that central replacement of the orexin neurotransmitter partially ameliorates lethargy following endotoxin treatment.
18. Harden LM, du Plessis I, Poole S, Laburn HP. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun 2008;22:838-849.
19. Scarlett JM, Zhu X, Enriori PJ, et al. Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology 2008;149:4837-4845.
20. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-1263.
21. Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-C32.
22. Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun 2012;26:830-848.
23. Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007;21:413-427.
24. Kemna E, Pickkers P, Nemeth E, et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-1866.
25. Sheng WS, Hu S, Ding JM, et al. Cytokine expression in the mouse brain in response to immune activation by Corynebacterium parvum. Clin Diagn Lab Immunol 2001;8:446-448.
26. Gilbertson-White S, Aouizerat BE, Miaskowski C. Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms. Biol Res Nurs 2011;13:15-24.
27. Kitamura H, Okamoto S, Shimamoto Y, et al. Central IL-1 differentially regulates peripheral IL-6 and TNF synthesis. Cell Mol Life Sci 1998;54:282-287.
28. Xiao E, Xia L, Ferin M, Wardlaw SL. Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin- 1 receptor antagonist into peripheral blood in the primate. J Neuroimmunol 1999;97:70-76.
29. Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007;21:413-427.
30. Liu L, Mills PJ, Rissling M, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 2012;26:706-713.
31. Ganz PA, Bower JE, Kwan L, et al. Does tumor necrosis factor-alpha (TNFalpha) play a role in postchemotherapy cerebral dysfunction? Brain Behav Immun 2012. [Epub ahead of print] This article represents one of the few clinical studies that support the review that cytotoxic chemotherapy-related cognitive dysfunction in cancer patients may be similar to sickness behavior and therefore caused by treatment-related increases in pro-inflammatory cytokines.
32. Collins B, Mackenzie J, Tasca GA et al. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology 2012. [Epub ahead of print]
33. Briones TL, Woods J. Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci 2011;12:124. This article demonstrates usefulness of an animal model in studying the effects of chemotherapy on brain neuron proliferation and cognitive function.
34. Christie LA, Acharya MM, Parihar VK, et al. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 2012;18:1954-1965.
35. Fardell JE, Vardy J, Shah JD, Johnston IN. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology (Berl) 2012;220:183-193.
36. MustrophML, Chen S, Desai SC, et al. Aerobic exercise is the critical variable in an enriched environment that increases hippocampal neurogenesis and water maze learning in male C57BL/6J mice. Neuroscience 2012;219:62-71.